Hepatic Dysfunction as a Complication of Adenosine Deaminase Deficiency
Open Access
- 23 May 1996
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (21), 1367-1372
- https://doi.org/10.1056/nejm199605233342104
Abstract
Complete deficiency of adenosine deaminase causes severe combined immunodeficiency that is inherited as an autosomal recessive trait. The patients present in infancy with recurrent infections, lymphopenia, defective proliferative responses to mitogens, hypogammaglobulinemia, and an inability to mount specific antibody responses. Patients with a low level of residual adenosine deaminase activity have a later onset of clinical disease owing to a slower and sometimes less complete loss of immune function.1-3Keywords
This publication has 30 references indexed in Scilit:
- Adenosine deaminase deficiency: molecular basis and recent developmentsClinical Immunology and Immunopathology, 1995
- PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 yearsClinical Immunology and Immunopathology, 1995
- Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5′ splice siteHuman Mutation, 1995
- PEG-ADA: An alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiencyHuman Mutation, 1995
- Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.Journal of Clinical Investigation, 1993
- Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patientsThe Journal of Pediatrics, 1993
- Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.Journal of Clinical Investigation, 1990
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987
- Amelioration of Neurologic Abnormalities after Enzyme Replacement in Adenosine Deaminase DeficiencyNew England Journal of Medicine, 1980
- Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cellsCell, 1977